XCE tirzepatide is a high purity pharmaceutical grade compound with CAS number 2023788-19-2. This white powder has a purity of 99% and is specifically designed for research purposes only.
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, XCE tirzepatide shows superior efficacy in glucose control and weight loss compared to selective GLP-1 receptor agonists. The compound demonstrates greater affinity to GIP receptors while maintaining significant activity at GLP-1 receptors.
Our XCE tirzepatide is available in various concentrations including 2mg, 5mg, 10mg, 15mg and 30mg vials. Custom packaging options are available for bulk orders with minimum order quantities starting from 1g.
For research applications, XCE tirzepatide has shown promising results in studies related to type 2 diabetes treatment. The dual agonist behavior produces greater reductions of hyperglycemia compared to selective GLP-1 receptor agonists.
All batches of XCE tirzepatide undergo rigorous quality control testing to ensure consistency and purity. The product is supplied with complete analytical documentation including HPLC and MS reports.
Note: This product is intended for research purposes only. Not for human or veterinary use.